nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—hepatitis B—acquired immunodeficiency syndrome	0.517	1	CtDrD
Adefovir Dipivoxil—NME2—Lamivudine—acquired immunodeficiency syndrome	0.0829	0.224	CbGbCtD
Adefovir Dipivoxil—NME1—Lamivudine—acquired immunodeficiency syndrome	0.0829	0.224	CbGbCtD
Adefovir Dipivoxil—NME1-NME2—Lamivudine—acquired immunodeficiency syndrome	0.0829	0.224	CbGbCtD
Adefovir Dipivoxil—ABCC5—Zidovudine—acquired immunodeficiency syndrome	0.0312	0.0843	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0164	0.0443	CbGbCtD
Adefovir Dipivoxil—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.015	0.0405	CbGbCtD
Adefovir Dipivoxil—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.0143	0.0386	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0124	0.0336	CbGbCtD
Adefovir Dipivoxil—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0116	0.0313	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.00938	0.0253	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.00653	0.0176	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.00505	0.0136	CbGbCtD
Adefovir Dipivoxil—NME2—blood plasma—acquired immunodeficiency syndrome	0.00169	0.0587	CbGeAlD
Adefovir Dipivoxil—AK4—retina—acquired immunodeficiency syndrome	0.000945	0.0329	CbGeAlD
Adefovir Dipivoxil—NME2—retina—acquired immunodeficiency syndrome	0.000924	0.0321	CbGeAlD
Adefovir Dipivoxil—NME1—skin of body—acquired immunodeficiency syndrome	0.000861	0.0299	CbGeAlD
Adefovir Dipivoxil—AK2—blood—acquired immunodeficiency syndrome	0.000855	0.0297	CbGeAlD
Adefovir Dipivoxil—AK2—bone marrow—acquired immunodeficiency syndrome	0.000827	0.0288	CbGeAlD
Adefovir Dipivoxil—AK2—vagina—acquired immunodeficiency syndrome	0.000792	0.0276	CbGeAlD
Adefovir Dipivoxil—AK2—lung—acquired immunodeficiency syndrome	0.000749	0.0261	CbGeAlD
Adefovir Dipivoxil—NME1—lymphoid tissue—acquired immunodeficiency syndrome	0.000697	0.0243	CbGeAlD
Adefovir Dipivoxil—NME1—Indinavir—Nelfinavir—acquired immunodeficiency syndrome	0.000695	0.389	CbGdCrCtD
Adefovir Dipivoxil—NME1—digestive system—acquired immunodeficiency syndrome	0.000689	0.024	CbGeAlD
Adefovir Dipivoxil—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000679	0.0236	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—acquired immunodeficiency syndrome	0.000676	0.0235	CbGeAlD
Adefovir Dipivoxil—AK4—digestive system—acquired immunodeficiency syndrome	0.000664	0.0231	CbGeAlD
Adefovir Dipivoxil—NME2—lymphoid tissue—acquired immunodeficiency syndrome	0.000657	0.0228	CbGeAlD
Adefovir Dipivoxil—NME2—digestive system—acquired immunodeficiency syndrome	0.000649	0.0226	CbGeAlD
Adefovir Dipivoxil—NME1—bone marrow—acquired immunodeficiency syndrome	0.000635	0.0221	CbGeAlD
Adefovir Dipivoxil—NME2—blood—acquired immunodeficiency syndrome	0.000618	0.0215	CbGeAlD
Adefovir Dipivoxil—AK4—spinal cord—acquired immunodeficiency syndrome	0.000609	0.0212	CbGeAlD
Adefovir Dipivoxil—AK4—vagina—acquired immunodeficiency syndrome	0.000586	0.0204	CbGeAlD
Adefovir Dipivoxil—NME1—lung—acquired immunodeficiency syndrome	0.000575	0.02	CbGeAlD
Adefovir Dipivoxil—NME1—Indinavir—Lopinavir—acquired immunodeficiency syndrome	0.000567	0.317	CbGdCrCtD
Adefovir Dipivoxil—AK4—lung—acquired immunodeficiency syndrome	0.000554	0.0193	CbGeAlD
Adefovir Dipivoxil—NME2—lung—acquired immunodeficiency syndrome	0.000542	0.0188	CbGeAlD
Adefovir Dipivoxil—ABCC5—retina—acquired immunodeficiency syndrome	0.000537	0.0187	CbGeAlD
Adefovir Dipivoxil—NME1—nervous system—acquired immunodeficiency syndrome	0.000533	0.0185	CbGeAlD
Adefovir Dipivoxil—AK2—brain—acquired immunodeficiency syndrome	0.00053	0.0185	CbGeAlD
Adefovir Dipivoxil—NME1—Indinavir—Saquinavir—acquired immunodeficiency syndrome	0.000527	0.295	CbGdCrCtD
Adefovir Dipivoxil—AK4—nervous system—acquired immunodeficiency syndrome	0.000513	0.0179	CbGeAlD
Adefovir Dipivoxil—NME1—central nervous system—acquired immunodeficiency syndrome	0.000513	0.0178	CbGeAlD
Adefovir Dipivoxil—AK2—lymph node—acquired immunodeficiency syndrome	0.000513	0.0178	CbGeAlD
Adefovir Dipivoxil—NME2—nervous system—acquired immunodeficiency syndrome	0.000502	0.0175	CbGeAlD
Adefovir Dipivoxil—AK4—central nervous system—acquired immunodeficiency syndrome	0.000494	0.0172	CbGeAlD
Adefovir Dipivoxil—NME2—central nervous system—acquired immunodeficiency syndrome	0.000483	0.0168	CbGeAlD
Adefovir Dipivoxil—NME1—brain—acquired immunodeficiency syndrome	0.000407	0.0142	CbGeAlD
Adefovir Dipivoxil—NME1—lymph node—acquired immunodeficiency syndrome	0.000393	0.0137	CbGeAlD
Adefovir Dipivoxil—AK4—brain—acquired immunodeficiency syndrome	0.000392	0.0136	CbGeAlD
Adefovir Dipivoxil—NME2—brain—acquired immunodeficiency syndrome	0.000383	0.0133	CbGeAlD
Adefovir Dipivoxil—AK4—lymph node—acquired immunodeficiency syndrome	0.000379	0.0132	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—acquired immunodeficiency syndrome	0.000371	0.0129	CbGeAlD
Adefovir Dipivoxil—ABCC5—bone marrow—acquired immunodeficiency syndrome	0.000347	0.0121	CbGeAlD
Adefovir Dipivoxil—ABCC5—vagina—acquired immunodeficiency syndrome	0.000333	0.0116	CbGeAlD
Adefovir Dipivoxil—ABCC5—lung—acquired immunodeficiency syndrome	0.000315	0.0109	CbGeAlD
Adefovir Dipivoxil—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000261	0.00909	CbGeAlD
Adefovir Dipivoxil—SLC22A6—brain—acquired immunodeficiency syndrome	0.000256	0.0089	CbGeAlD
Adefovir Dipivoxil—ABCC4—blood—acquired immunodeficiency syndrome	0.000249	0.00866	CbGeAlD
Adefovir Dipivoxil—SLC22A8—blood—acquired immunodeficiency syndrome	0.000247	0.00859	CbGeAlD
Adefovir Dipivoxil—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000241	0.00837	CbGeAlD
Adefovir Dipivoxil—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000238	0.00827	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lung—acquired immunodeficiency syndrome	0.000225	0.00783	CbGeAlD
Adefovir Dipivoxil—ABCC5—brain—acquired immunodeficiency syndrome	0.000223	0.00775	CbGeAlD
Adefovir Dipivoxil—ABCC4—lung—acquired immunodeficiency syndrome	0.000218	0.00759	CbGeAlD
Adefovir Dipivoxil—ABCC5—lymph node—acquired immunodeficiency syndrome	0.000215	0.00749	CbGeAlD
Adefovir Dipivoxil—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000208	0.00725	CbGeAlD
Adefovir Dipivoxil—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000202	0.00703	CbGeAlD
Adefovir Dipivoxil—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000201	0.00698	CbGeAlD
Adefovir Dipivoxil—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.0002	0.00697	CbGeAlD
Adefovir Dipivoxil—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000194	0.00676	CbGeAlD
Adefovir Dipivoxil—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000193	0.00671	CbGeAlD
Adefovir Dipivoxil—SLC22A3—brain—acquired immunodeficiency syndrome	0.000159	0.00554	CbGeAlD
Adefovir Dipivoxil—ABCC4—brain—acquired immunodeficiency syndrome	0.000154	0.00537	CbGeAlD
Adefovir Dipivoxil—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000154	0.00535	CbGeAlD
Adefovir Dipivoxil—SLC22A8—brain—acquired immunodeficiency syndrome	0.000153	0.00533	CbGeAlD
Adefovir Dipivoxil—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000149	0.00519	CbGeAlD
Adefovir Dipivoxil—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.00145	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.00145	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.00144	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000118	0.00144	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00144	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000118	0.00144	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00144	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.00143	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000117	0.00143	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000117	0.00143	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.00141	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.00141	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000116	0.00141	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.0014	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.0014	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000114	0.00139	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00139	CcSEcCtD
Adefovir Dipivoxil—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.00139	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000114	0.00139	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.00139	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000113	0.00138	CcSEcCtD
Adefovir Dipivoxil—Cough—Indinavir—acquired immunodeficiency syndrome	0.000113	0.00138	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000113	0.00138	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.00137	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000112	0.00137	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.00137	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.00136	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000112	0.00136	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.00136	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.00135	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00135	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00135	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00134	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.00133	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00133	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.00133	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000108	0.00132	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.00131	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000107	0.00131	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000106	0.00129	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000105	0.00129	CcSEcCtD
Adefovir Dipivoxil—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00128	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.00128	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00128	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00128	CcSEcCtD
Adefovir Dipivoxil—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000105	0.00128	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000104	0.00128	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000104	0.00127	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000103	0.00126	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.00126	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000103	0.00126	CcSEcCtD
Adefovir Dipivoxil—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.00125	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000102	0.00125	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000102	0.00125	CcSEcCtD
Adefovir Dipivoxil—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00123	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000101	0.00123	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.00123	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.00123	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00122	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00122	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	9.98e-05	0.00122	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	9.91e-05	0.00121	CcSEcCtD
Adefovir Dipivoxil—Nausea—Amprenavir—acquired immunodeficiency syndrome	9.85e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	9.85e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Lamivudine—acquired immunodeficiency syndrome	9.83e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	9.83e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	9.81e-05	0.0012	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Nevirapine—acquired immunodeficiency syndrome	9.75e-05	0.00119	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.00119	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.00118	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	9.66e-05	0.00118	CcSEcCtD
Adefovir Dipivoxil—Back pain—Lamivudine—acquired immunodeficiency syndrome	9.65e-05	0.00118	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Nevirapine—acquired immunodeficiency syndrome	9.62e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Didanosine—acquired immunodeficiency syndrome	9.61e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Efavirenz—acquired immunodeficiency syndrome	9.55e-05	0.00117	CcSEcCtD
Adefovir Dipivoxil—Rash—Didanosine—acquired immunodeficiency syndrome	9.53e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Didanosine—acquired immunodeficiency syndrome	9.52e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Cough—Ritonavir—acquired immunodeficiency syndrome	9.48e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Headache—Didanosine—acquired immunodeficiency syndrome	9.47e-05	0.00116	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	9.44e-05	0.00115	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Stavudine—acquired immunodeficiency syndrome	9.41e-05	0.00115	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	9.39e-05	0.00115	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	9.34e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	9.33e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	9.31e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	9.3e-05	0.00114	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Stavudine—acquired immunodeficiency syndrome	9.28e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Abacavir—acquired immunodeficiency syndrome	9.27e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	9.22e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.00113	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.00112	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.16e-05	0.00112	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.15e-05	0.00112	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.14e-05	0.00112	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.13e-05	0.00111	CcSEcCtD
Adefovir Dipivoxil—Cough—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.00111	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.02e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.02e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.01e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	8.98e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Nausea—Didanosine—acquired immunodeficiency syndrome	8.98e-05	0.0011	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.00109	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.00109	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	8.84e-05	0.00108	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.00108	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	8.82e-05	0.00108	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	8.74e-05	0.00107	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	8.71e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Cough—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	8.68e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	8.67e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	8.65e-05	0.00106	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	8.64e-05	0.00105	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.00105	CcSEcCtD
Adefovir Dipivoxil—Rash—Nevirapine—acquired immunodeficiency syndrome	8.57e-05	0.00105	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	8.56e-05	0.00105	CcSEcCtD
Adefovir Dipivoxil—Headache—Nevirapine—acquired immunodeficiency syndrome	8.51e-05	0.00104	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.00104	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.00104	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.45e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	8.44e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	8.43e-05	0.00103	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.38e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.38e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.37e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.37e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	8.36e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.34e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.34e-05	0.00102	CcSEcCtD
Adefovir Dipivoxil—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.3e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.29e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.28e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Rash—Stavudine—acquired immunodeficiency syndrome	8.27e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.27e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.25e-05	0.00101	CcSEcCtD
Adefovir Dipivoxil—Headache—Stavudine—acquired immunodeficiency syndrome	8.22e-05	0.001	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.22e-05	0.001	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.19e-05	0.001	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.18e-05	0.000999	CcSEcCtD
Adefovir Dipivoxil—Rash—Abacavir—acquired immunodeficiency syndrome	8.15e-05	0.000995	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.14e-05	0.000994	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.14e-05	0.000993	CcSEcCtD
Adefovir Dipivoxil—Headache—Abacavir—acquired immunodeficiency syndrome	8.1e-05	0.000989	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.08e-05	0.000986	CcSEcCtD
Adefovir Dipivoxil—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.07e-05	0.000986	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.07e-05	0.000985	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	7.98e-05	0.000975	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	7.97e-05	0.000973	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	7.92e-05	0.000967	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	7.92e-05	0.000967	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.000965	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	7.84e-05	0.000957	CcSEcCtD
Adefovir Dipivoxil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	7.82e-05	0.000954	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	7.81e-05	0.000953	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	7.8e-05	0.000953	CcSEcCtD
Adefovir Dipivoxil—Nausea—Stavudine—acquired immunodeficiency syndrome	7.79e-05	0.000952	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	7.78e-05	0.000949	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	7.76e-05	0.000947	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	7.71e-05	0.000941	CcSEcCtD
Adefovir Dipivoxil—Nausea—Abacavir—acquired immunodeficiency syndrome	7.68e-05	0.000937	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	7.66e-05	0.000935	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Indinavir—acquired immunodeficiency syndrome	7.61e-05	0.000929	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	7.58e-05	0.000925	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	7.58e-05	0.000925	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	7.51e-05	0.000917	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.5e-05	0.000916	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.42e-05	0.000906	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.42e-05	0.000906	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.37e-05	0.0009	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000886	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.25e-05	0.000885	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.25e-05	0.000885	CcSEcCtD
Adefovir Dipivoxil—Rash—Zidovudine—acquired immunodeficiency syndrome	7.19e-05	0.000878	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.19e-05	0.000878	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.18e-05	0.000877	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.17e-05	0.000875	CcSEcCtD
Adefovir Dipivoxil—Headache—Zidovudine—acquired immunodeficiency syndrome	7.14e-05	0.000872	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.09e-05	0.000866	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.08e-05	0.000864	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.03e-05	0.000858	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000856	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000856	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.98e-05	0.000852	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	6.88e-05	0.00084	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000837	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	6.78e-05	0.000828	CcSEcCtD
Adefovir Dipivoxil—Nausea—Zidovudine—acquired immunodeficiency syndrome	6.77e-05	0.000827	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000824	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	6.75e-05	0.000824	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Indinavir—acquired immunodeficiency syndrome	6.74e-05	0.000823	CcSEcCtD
Adefovir Dipivoxil—Rash—Indinavir—acquired immunodeficiency syndrome	6.69e-05	0.000816	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	6.68e-05	0.000816	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	6.66e-05	0.000813	CcSEcCtD
Adefovir Dipivoxil—Headache—Indinavir—acquired immunodeficiency syndrome	6.64e-05	0.000811	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.000801	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000786	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.44e-05	0.000786	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.37e-05	0.000778	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.000777	CcSEcCtD
Adefovir Dipivoxil—Rash—Efavirenz—acquired immunodeficiency syndrome	6.32e-05	0.000771	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.31e-05	0.000771	CcSEcCtD
Adefovir Dipivoxil—Nausea—Indinavir—acquired immunodeficiency syndrome	6.3e-05	0.000769	CcSEcCtD
Adefovir Dipivoxil—Headache—Efavirenz—acquired immunodeficiency syndrome	6.28e-05	0.000766	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.27e-05	0.000766	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.12e-05	0.000748	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.1e-05	0.000744	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000741	CcSEcCtD
Adefovir Dipivoxil—Rash—Delavirdine—acquired immunodeficiency syndrome	6.05e-05	0.000738	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.000737	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.04e-05	0.000737	CcSEcCtD
Adefovir Dipivoxil—Headache—Delavirdine—acquired immunodeficiency syndrome	6.01e-05	0.000733	CcSEcCtD
Adefovir Dipivoxil—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.95e-05	0.000727	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000713	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000713	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	5.76e-05	0.000703	CcSEcCtD
Adefovir Dipivoxil—Nausea—Delavirdine—acquired immunodeficiency syndrome	5.7e-05	0.000695	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.64e-05	0.000688	CcSEcCtD
Adefovir Dipivoxil—Rash—Ritonavir—acquired immunodeficiency syndrome	5.59e-05	0.000683	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.59e-05	0.000682	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.00068	CcSEcCtD
Adefovir Dipivoxil—Headache—Ritonavir—acquired immunodeficiency syndrome	5.55e-05	0.000678	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000662	CcSEcCtD
Adefovir Dipivoxil—Rash—Saquinavir—acquired immunodeficiency syndrome	5.38e-05	0.000657	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.38e-05	0.000656	CcSEcCtD
Adefovir Dipivoxil—Headache—Saquinavir—acquired immunodeficiency syndrome	5.35e-05	0.000653	CcSEcCtD
Adefovir Dipivoxil—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.27e-05	0.000643	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000632	CcSEcCtD
Adefovir Dipivoxil—Rash—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000627	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000626	CcSEcCtD
Adefovir Dipivoxil—Headache—Lamivudine—acquired immunodeficiency syndrome	5.1e-05	0.000623	CcSEcCtD
Adefovir Dipivoxil—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.07e-05	0.000619	CcSEcCtD
Adefovir Dipivoxil—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.84e-05	0.00059	CcSEcCtD
